Limited submission opportunity: V Foundation 2018 Translational Research Awards

Vanderbilt (VU + VUMC, collaboratively) anticipates the opportunity to choose one nominee for the V Foundation 2018 Translational Research Award. The Translational Research award is a $600,000 grant awarded in three annual installments of $200,000. Indirect costs up to a maximum of 10 percent within the total award are permitted.

Definition of a translational research project: Translational projects should move a novel strategy from the laboratory into a human clinical trial or use specimens from a clinical trial to develop biomarkers or mechanisms. The research should apply in some direct way to human beings within the time frame of less than three years. If biomarker research is undertaken, a validation set or independent clinical trial is essential. A plan for biomarker validation, if applicable, must be included in any proposal. The endpoint of the project should be the planning or initiation of a new clinical trial.

Any area of cancer research is permitted. However, research on the biological basis of cancer disparities experienced by patients from minority ethnic or racial populations in areas related to causes, aggressiveness, treatment or relapse is encouraged. Cancers in which ethnic and racial disparities have previously been demonstrated include: lung and bronchus, colon and rectum, breast, prostate, uterine, cervix, stomach and liver. At least one of the highest ranked applications will be designated as the recipient of a Stuart Scott Memorial Fund Translational Research Award.

Note that this call is distinct from the call for V Scholar Award. Contact for more information.


Eligibility Criteria:

By May 30, 2018, the applicant who will lead a proposed research team must meet all the following:

  • Be a scientist who holds a tenure-track faculty position at their cancer research institution. Non-promotable, adjunct, affiliated, temporary, part-time or acting faculty positions are not eligible for Principal Investigator nomination to lead the Translational Research Team.
  • Be either a U.S. citizen or have a legal permit to work in the USA (either temporary or permanent).


Internal Selection Process:

Anyone interested in being considered as Vanderbilt’s nominee must submit the following (in a single PDF) to by 5 p.m. on Thursday, March 29, 2018:

  1. Research plan including summary budget (two-page maximum);
  2. Brief statement of support from department chair/center director;
  3. NIH Biosketch


Submissions should reference “2018 V Foundation Translational Research Award–All Cancer Research” in the subject line of the email. Please contact us at if you have any questions.